Educating QUitline Callers About Lung Cancer Screening
EQUAL
Testing Methods to Increase Lung Cancer Screening Among Quitline Callers
1 other identifier
interventional
298
1 country
1
Brief Summary
The specific aims are:
- 1.To evaluate the potential barriers of providing educational lung screening interventions to quitline users, the investigators will seek input from 10-20 stakeholders on the newly adapted print version of the Should I Screen website, and on our proposed Aim 2 recruitment and retention procedures.
- 2.To conduct a randomized intervention, comparing: 1) ShouldIScreen.com website, (WEB; N=150); vs. 2) the Should I Screen print version (PRINT; N=150). H2.1. At 1- and 4-months post-randomization, the WEB arm will have significantly higher lung screening knowledge and intention to undergo lung screening, compared to PRINT. Randomization will be stratified by age and pack-years in order to incorporate those who are recently eligible for screening, ages 50-54 and with 20-29 pack years. H2.2 The investigators will explore several potential moderators (age and e-health literacy). For example, the investigators will explore whether older vs younger participants have differential knowledge outcomes when using the PRINT vs WEB interventions. H2.3 We will explore whether mediators (prior lung screening, current primary care provider, lung cancer perceived risk) positively affects knowledge and screening intentions.
- 3.To evaluate reach (% of quitline users enrolled) and engagement (% who read the intervention materials) by study arm and subgroup (e.g., method of quitline access, age, e-health literacy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started May 2021
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2021
CompletedFirst Submitted
Initial submission to the registry
June 8, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMarch 29, 2023
March 1, 2023
1.1 years
June 8, 2021
March 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Reach of eligible quitline users
% of eligible quitline users enrolled in the trial;
baseline assessment
Intervention Engagement of eligible quitline users
WEB: electronic assessment of 1) logged on, 2) total time spent on website, 3) sections accessed; PRINT: self-reported time spent reading;
one month assessment
Satisfaction with the intervention materials.
Assessment of satisfaction with length, format, and content of the materials
one month assessment
Lung cancer screening knowledge
Assessment of lung cancer risk factors, screening eligibility, and pros/cons of screening
one month assessment
Lung cancer screening knowledge
Assessment of lung cancer risk factors, screening eligibility, and pros/cons of screening
four month assessment
Percentage of participants who intend to undergo lung cancer screening
Intent to undergo lung cancer screening
one month assessment
Percentage of participants who intend to undergo lung cancer screening
Intent to undergo lung cancer screening
four month assessment
Secondary Outcomes (2)
Percentage of participants with an appointment for a shared decision making visit
one month assessment
Percentage of participants with an appointment for a shared decision making visit
four month assessment
Study Arms (2)
Web arm
ACTIVE COMPARATORThe Should I Screen educational website, developed by our consultant, Rafael Meza, PhD, is available at no cost, is written at an 8th grade reading level, requires 15 minutes to use, and undergoes regular updates (https://shouldiscreen.com). The goal is to increase lung screening awareness and to encourage a shared decision making visit with a provider. Sections of the website include the benefits (the reduced likelihood of dying from lung cancer) and harms (false alarms, overdiagnosis, more testing, and invasive procedures) of screening, causes of lung cancer, methods to reduce lung cancer risk, and the lung cancer risk calculator. Improvements in knowledge have been demonstrated with individuals eligible for screening.
Print Arm
ACTIVE COMPARATORThe Should I Screen print-based education (included with this IRB protocol) will be developed in Aim 1 and compared to the Should I Screen website in Aim 2. It will also be at the 8th grade level and will require 15 minutes to read. Although it will contain the same topics as the website, there is one inherent difference - it is not possible to include the interactive risk calculator in the print version. The print-based version will list all of the risk criteria that are included in the algorithm so that participants can see which ones apply to them. However, the risk calculator requires the computer algorithm to calculate a person's 6-year risk of developing lung cancer.
Interventions
The Should I Screen educational website, developed by our consultant, Rafael Meza, PhD, is available at no cost, is written at an 8th grade reading level, requires 15 minutes to use, and undergoes regular updates (https://shouldiscreen.com). The goal is to increase lung screening awareness and to encourage a shared decision making visit with a provider. Sections of the website include the benefits (the reduced likelihood of dying from lung cancer) and harms (false alarms, overdiagnosis, more testing, and invasive procedures) of screening, causes of lung cancer, methods to reduce lung cancer risk, and the lung cancer risk calculator. Improvements in knowledge have been demonstrated with individuals eligible for screening.
The Should I Screen print-based education will be developed in Aim 1 and compared to the Should I Screen website in Aim 2. It will also be at the 8th grade level and will require 15 minutes to read. Although it will contain the same topics as the website, there is one inherent difference - it is not possible to include the interactive risk calculator in the print version. The print-based version will list all of the risk criteria that are included in the algorithm so that participants can see which ones apply to them. However, the risk calculator requires the computer algorithm to calculate a person's 6-year risk of developing lung cancer.
Eligibility Criteria
You may qualify if:
- enrolled in the quitline
- years old
- \>20-pack year smoking history
- never screened or \>12 months since prior screen
- English speaking
- able to provide meaningful consent
- no family members in the same household enrolled in the trial
- prior lung cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Georgetown Universitylead
- American Lung Associationcollaborator
Study Sites (1)
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
Related Publications (1)
Webster M, Whealan J, Williams RM, Eyestone E, Le A, Childs J, Kao JY, Martin M, Wolfe S, Yang F, Hung PY, Lau YK, Luta G, Tammemagi M, Meza R, Taylor KL. The tobacco quitline setting as a teachable moment: The Educating Quitline Users About Lung (EQUAL) cancer screening randomized trial. Transl Behav Med. 2023 Sep 28;13(10):736-747. doi: 10.1093/tbm/ibad049.
PMID: 37616531BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2021
First Posted
September 16, 2021
Study Start
May 27, 2021
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
March 29, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- The data will be availble for one year following the date of publication.
- Access Criteria
- Email the corresponding author with the request. Kathryn L. Taylor, taylorkl@georgetown.edu
Interested researchers can email the corresponding author to request access to deidentified data. A data analyais plan and IRB approval will be required.